Cargando…
Altered human gut virome in patients undergoing antibiotics therapy for Helicobacter pylori
Transient gut microbiota alterations have been reported after antibiotic therapy for Helicobacter pylori. However, alteration in the gut virome after H. pylori eradication remains uncertain. Here, we apply metagenomic sequencing to fecal samples of 44 H. pylori-infected patients at baseline, 6-week...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110541/ https://www.ncbi.nlm.nih.gov/pubmed/37069161 http://dx.doi.org/10.1038/s41467-023-37975-y |
_version_ | 1785027282525487104 |
---|---|
author | Wang, Lingling Yao, Haobin Morgan, Daniel C. Lau, Kam Shing Leung, Suet Yi Ho, Joshua W. K. Leung, Wai K. |
author_facet | Wang, Lingling Yao, Haobin Morgan, Daniel C. Lau, Kam Shing Leung, Suet Yi Ho, Joshua W. K. Leung, Wai K. |
author_sort | Wang, Lingling |
collection | PubMed |
description | Transient gut microbiota alterations have been reported after antibiotic therapy for Helicobacter pylori. However, alteration in the gut virome after H. pylori eradication remains uncertain. Here, we apply metagenomic sequencing to fecal samples of 44 H. pylori-infected patients at baseline, 6-week (N = 44), and 6-month (N = 33) after treatment. Following H. pylori eradication, we discover contraction of the gut virome diversity, separation of virome community with increased community difference, and shifting towards a higher proportion of core virus. While the gut microbiota is altered at 6-week and restored at 6-month, the virome community shows contraction till 6-month after the treatment with enhanced phage-bacteria interactions at 6-week. Multiple courses of antibiotic treatments further lead to lower virus community diversity when compared with treatment naive patients. Our results demonstrate that H. pylori eradication therapies not only result in transient alteration in gut microbiota but also significantly alter the previously less known gut virome community. |
format | Online Article Text |
id | pubmed-10110541 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-101105412023-04-19 Altered human gut virome in patients undergoing antibiotics therapy for Helicobacter pylori Wang, Lingling Yao, Haobin Morgan, Daniel C. Lau, Kam Shing Leung, Suet Yi Ho, Joshua W. K. Leung, Wai K. Nat Commun Article Transient gut microbiota alterations have been reported after antibiotic therapy for Helicobacter pylori. However, alteration in the gut virome after H. pylori eradication remains uncertain. Here, we apply metagenomic sequencing to fecal samples of 44 H. pylori-infected patients at baseline, 6-week (N = 44), and 6-month (N = 33) after treatment. Following H. pylori eradication, we discover contraction of the gut virome diversity, separation of virome community with increased community difference, and shifting towards a higher proportion of core virus. While the gut microbiota is altered at 6-week and restored at 6-month, the virome community shows contraction till 6-month after the treatment with enhanced phage-bacteria interactions at 6-week. Multiple courses of antibiotic treatments further lead to lower virus community diversity when compared with treatment naive patients. Our results demonstrate that H. pylori eradication therapies not only result in transient alteration in gut microbiota but also significantly alter the previously less known gut virome community. Nature Publishing Group UK 2023-04-17 /pmc/articles/PMC10110541/ /pubmed/37069161 http://dx.doi.org/10.1038/s41467-023-37975-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Wang, Lingling Yao, Haobin Morgan, Daniel C. Lau, Kam Shing Leung, Suet Yi Ho, Joshua W. K. Leung, Wai K. Altered human gut virome in patients undergoing antibiotics therapy for Helicobacter pylori |
title | Altered human gut virome in patients undergoing antibiotics therapy for Helicobacter pylori |
title_full | Altered human gut virome in patients undergoing antibiotics therapy for Helicobacter pylori |
title_fullStr | Altered human gut virome in patients undergoing antibiotics therapy for Helicobacter pylori |
title_full_unstemmed | Altered human gut virome in patients undergoing antibiotics therapy for Helicobacter pylori |
title_short | Altered human gut virome in patients undergoing antibiotics therapy for Helicobacter pylori |
title_sort | altered human gut virome in patients undergoing antibiotics therapy for helicobacter pylori |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110541/ https://www.ncbi.nlm.nih.gov/pubmed/37069161 http://dx.doi.org/10.1038/s41467-023-37975-y |
work_keys_str_mv | AT wanglingling alteredhumangutviromeinpatientsundergoingantibioticstherapyforhelicobacterpylori AT yaohaobin alteredhumangutviromeinpatientsundergoingantibioticstherapyforhelicobacterpylori AT morgandanielc alteredhumangutviromeinpatientsundergoingantibioticstherapyforhelicobacterpylori AT laukamshing alteredhumangutviromeinpatientsundergoingantibioticstherapyforhelicobacterpylori AT leungsuetyi alteredhumangutviromeinpatientsundergoingantibioticstherapyforhelicobacterpylori AT hojoshuawk alteredhumangutviromeinpatientsundergoingantibioticstherapyforhelicobacterpylori AT leungwaik alteredhumangutviromeinpatientsundergoingantibioticstherapyforhelicobacterpylori |